L Catterton, a private equity firm that invests in all major consumer segments, completed the acquisition of Thorne HealthTech, a science-driven wellness company, for $680m. "As consumer investors, we closely follow enduring secular trends, including the consumer's increasing prioritization of health and wellness. As we begin this partnership with Thorne, returning this leading clinical brand to the private market, we look forward to focusing our resources and strategic planning on executing on Thorne's vision of delivering clinically backed outcomes utilizing specialized health tests and personalized supplement and wellness programs to patients around the globe," Marc Magliacano, L Catterton Co-Managing Partner of the Flagship Fund.